{
    "info": {
        "nct_id": "NCT02963064",
        "official_title": "A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of JSP191 for Hematopoietic Cell Transplantation Conditioning to Achieve Engraftment and Immune Reconstitution in Subjects with SCID",
        "inclusion_criteria": "1. Typical SCID as defined by Primary Immune Deficiency Treatment Consortia including but not limited to the following subtypes:\n\n   1. T-, B+, NK-: IL-2Rcγ deficient, JAK3-deficient (no longer enrolling)\n   2. T-, B-, NK+: RAG1/2 deficient, Artemis-deficient\n   3. T-, B+, NK+: IL7Rα deficient, CD3 subunit deficient, CD45 deficient (no longer enrolling) OR Variant SCID with absent or low T cell function, Omenn syndrome, Leaky SCID, Reticular dysgenesis, Adenosine deaminase deficiency, and Purine nucleoside phosphorylase deficiency may be included after consultation with the medical monitor.\n2. Patients with human leukocyte antigen (HLA) matched related or unrelated donors\n3. Adequate end organ function as defined in study protocol\n4. Age ≤ 12 years\n5. Prior donor of appropriate age (≥ 5 years old) available for re-collection of stem cells\n6. Previous allogeneic Hematopoietic Cell Transplantation HCT (≥ 6 months post initial transplant) with poor graft function\n\nKey\nHealthy volunteers allowed\nMust have minimum age of 3 Months\nMust have maximum age of 12 Years",
        "exclusion_criteria": "1. Patients with any acute or uncontrolled infections\n2. Patients receiving any other investigational agents, or concurrent biological, chemotherapy, or radiation therapy\n3. Patients with active malignancies\n4. Active GVHD within 6 months prior to enrollment, or on immunosuppressive therapy for GVHD",
        "miscellaneous_criteria": "Key"
    },
    "inclusion_lines": [
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Adequate end organ function as defined in study protocol",
            "criterions": [
                {
                    "exact_snippets": "Adequate end organ function as defined in study protocol",
                    "criterion": "end organ function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "definition source",
                            "expected_value": "as defined in study protocol"
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. T-, B-, NK+: RAG1/2 deficient, Artemis-deficient",
            "criterions": [
                {
                    "exact_snippets": "T-, B-, NK+",
                    "criterion": "lymphocyte subsets",
                    "requirements": [
                        {
                            "requirement_type": "T cell presence",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "B cell presence",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "NK cell presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "RAG1/2 deficient",
                    "criterion": "RAG1/2 gene function",
                    "requirements": [
                        {
                            "requirement_type": "deficiency",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Artemis-deficient",
                    "criterion": "Artemis gene function",
                    "requirements": [
                        {
                            "requirement_type": "deficiency",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Prior donor of appropriate age (≥ 5 years old) available for re-collection of stem cells",
            "criterions": [
                {
                    "exact_snippets": "Prior donor of appropriate age (≥ 5 years old) available",
                    "criterion": "prior donor",
                    "requirements": [
                        {
                            "requirement_type": "availability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "age",
                            "expected_value": {
                                "operator": ">=",
                                "value": 5,
                                "unit": "years"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "available for re-collection of stem cells",
                    "criterion": "prior donor",
                    "requirements": [
                        {
                            "requirement_type": "eligibility for re-collection of stem cells",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Previous allogeneic Hematopoietic Cell Transplantation HCT (≥ 6 months post initial transplant) with poor graft function",
            "criterions": [
                {
                    "exact_snippets": "Previous allogeneic Hematopoietic Cell Transplantation HCT",
                    "criterion": "allogeneic Hematopoietic Cell Transplantation (HCT)",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "(≥ 6 months post initial transplant)",
                    "criterion": "time since initial allogeneic HCT",
                    "requirements": [
                        {
                            "requirement_type": "time since transplant",
                            "expected_value": {
                                "operator": ">=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "poor graft function",
                    "criterion": "graft function",
                    "requirements": [
                        {
                            "requirement_type": "function",
                            "expected_value": "poor"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Key",
            "criterions": [
                {
                    "exact_snippets": "Key",
                    "criterion": "key eligibility criteria",
                    "requirements": [
                        {
                            "requirement_type": "N/A",
                            "expected_value": "N/A"
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. T-, B+, NK+: IL7Rα deficient, CD3 subunit deficient, CD45 deficient (no longer enrolling) OR Variant SCID with absent or low T cell function, Omenn syndrome, Leaky SCID, Reticular dysgenesis, Adenosine deaminase deficiency, and Purine nucleoside phosphorylase deficiency may be included after consultation with the medical monitor.",
            "criterions": [
                {
                    "exact_snippets": "T-, B+, NK+",
                    "criterion": "lymphocyte subset profile",
                    "requirements": [
                        {
                            "requirement_type": "T cell presence",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "B cell presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "NK cell presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "IL7Rα deficient",
                    "criterion": "IL7Rα deficiency",
                    "requirements": [
                        {
                            "requirement_type": "deficiency",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "CD3 subunit deficient",
                    "criterion": "CD3 subunit deficiency",
                    "requirements": [
                        {
                            "requirement_type": "deficiency",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "CD45 deficient (no longer enrolling)",
                    "criterion": "CD45 deficiency",
                    "requirements": [
                        {
                            "requirement_type": "deficiency",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "enrollment status",
                            "expected_value": "no longer enrolling"
                        }
                    ]
                },
                {
                    "exact_snippets": "Variant SCID with absent or low T cell function",
                    "criterion": "variant SCID with T cell function",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": "variant SCID"
                        },
                        {
                            "requirement_type": "T cell function",
                            "expected_value": [
                                "absent",
                                "low"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "Omenn syndrome",
                    "criterion": "Omenn syndrome",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Leaky SCID",
                    "criterion": "Leaky SCID",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Reticular dysgenesis",
                    "criterion": "Reticular dysgenesis",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Adenosine deaminase deficiency",
                    "criterion": "Adenosine deaminase deficiency",
                    "requirements": [
                        {
                            "requirement_type": "deficiency",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Purine nucleoside phosphorylase deficiency",
                    "criterion": "Purine nucleoside phosphorylase deficiency",
                    "requirements": [
                        {
                            "requirement_type": "deficiency",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Age ≤ 12 years",
            "criterions": [
                {
                    "exact_snippets": "Age ≤ 12 years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": "<=",
                                "value": 12,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. T-, B+, NK-: IL-2Rcγ deficient, JAK3-deficient (no longer enrolling)",
            "criterions": [
                {
                    "exact_snippets": "T-, B+, NK-",
                    "criterion": "lymphocyte subsets",
                    "requirements": [
                        {
                            "requirement_type": "T cell presence",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "B cell presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "NK cell presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "IL-2Rcγ deficient",
                    "criterion": "IL-2 receptor gamma chain (IL-2Rcγ)",
                    "requirements": [
                        {
                            "requirement_type": "deficiency",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "JAK3-deficient",
                    "criterion": "JAK3",
                    "requirements": [
                        {
                            "requirement_type": "deficiency",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 3 Months",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 3 Months",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "Months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Typical SCID as defined by Primary Immune Deficiency Treatment Consortia including but not limited to the following subtypes:",
            "criterions": [
                {
                    "exact_snippets": "Typical SCID as defined by Primary Immune Deficiency Treatment Consortia",
                    "criterion": "typical SCID diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": "typical SCID as defined by Primary Immune Deficiency Treatment Consortia"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have maximum age of 12 Years",
            "criterions": [
                {
                    "exact_snippets": "maximum age of 12 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 12,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Patients with human leukocyte antigen (HLA) matched related or unrelated donors",
            "criterions": [
                {
                    "exact_snippets": "Patients with human leukocyte antigen (HLA) matched related or unrelated donors",
                    "criterion": "HLA donor match",
                    "requirements": [
                        {
                            "requirement_type": "match type",
                            "expected_value": [
                                "related",
                                "unrelated"
                            ]
                        },
                        {
                            "requirement_type": "HLA matching",
                            "expected_value": "matched"
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "2. Patients receiving any other investigational agents, or concurrent biological, chemotherapy, or radiation therapy",
            "criterions": [
                {
                    "exact_snippets": "Patients receiving any other investigational agents",
                    "criterion": "use of investigational agents",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "concurrent biological ... therapy",
                    "criterion": "concurrent biological therapy",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "concurrent ... chemotherapy",
                    "criterion": "concurrent chemotherapy",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "concurrent ... radiation therapy",
                    "criterion": "concurrent radiation therapy",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Patients with any acute or uncontrolled infections",
            "criterions": [
                {
                    "exact_snippets": "any acute or uncontrolled infections",
                    "criterion": "infections",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "status",
                            "expected_value": [
                                "acute",
                                "uncontrolled"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Active GVHD within 6 months prior to enrollment, or on immunosuppressive therapy for GVHD",
            "criterions": [
                {
                    "exact_snippets": "Active GVHD within 6 months prior to enrollment",
                    "criterion": "graft-versus-host disease (GVHD)",
                    "requirements": [
                        {
                            "requirement_type": "activity_status",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "time_since_last_occurrence",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "on immunosuppressive therapy for GVHD",
                    "criterion": "immunosuppressive therapy for GVHD",
                    "requirements": [
                        {
                            "requirement_type": "current_treatment_status",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Patients with active malignancies",
            "criterions": [
                {
                    "exact_snippets": "Patients with active malignancies",
                    "criterion": "active malignancy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [
        {
            "line": "Key",
            "criterions": [
                {
                    "exact_snippets": "Key",
                    "criterion": "key status",
                    "requirements": [
                        {
                            "requirement_type": "N/A",
                            "expected_value": "N/A"
                        }
                    ]
                }
            ]
        }
    ],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}